A detailed history of Morse Asset Management, Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Morse Asset Management, Inc holds 44,009 shares of ADMA stock, worth $642,091. This represents 0.19% of its overall portfolio holdings.

Number of Shares
44,009
Previous 8,700 405.85%
Holding current value
$642,091
Previous $172,000 365.7%
% of portfolio
0.19%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 15, 2025

BUY
$17.6 - $24.51 $621,438 - $865,423
35,309 Added 405.85%
44,009 $801,000
Q1 2025

May 05, 2025

BUY
$15.44 - $20.61 $21,616 - $28,854
1,400 Added 19.18%
8,700 $172,000
Q4 2024

Feb 14, 2025

BUY
$15.62 - $22.62 $110,511 - $160,036
7,075 Added 3144.44%
7,300 $125,000
Q3 2024

Nov 14, 2024

BUY
$11.21 - $20.03 $2,522 - $4,506
225 New
225 $4,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $2.86B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Morse Asset Management, Inc Portfolio

Follow Morse Asset Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morse Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Morse Asset Management, Inc with notifications on news.